-
A New Era for Diabetes Care: FDA Approves Awiqli for Children and Adolescents
NYSE: $NVO A Breakthrough in Insulin Therapy Managing type 1 and type 2 diabetes has long required the demanding routine of daily insulin injections. However, a significant advancement has arrived. The FDA has officially approved Awiqli (insulin icodec), marking it as the first and only once-weekly basal insulin for children and adolescents aged 10 years…
-
BIO-TECH STOCK CATALYST REPORT FOR WEEK OF 01-18-2026 TO 01-24-2026
We’re excited to announce the release of our latest bio tech stock catalyst report for the upcoming week. This new stock report highlights bio tech companies that have an upcoming important event to help traders and investors make informed decisions in today’s dynamic environment. Each stock symbol is a link to a stock quote page…
$ABBV, $AZN, $ELDN, $GMAB, $GNLX, $LLY, $LTRN, $MNKD, $NOV, $NVO, $NVS, $PFE, $SNY, biopharmaceutical, clinical-research, fda, new drug application, pr-newswire, press-releases